Literature DB >> 9209951

Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.

S Tenner1, C Fernandez-del Castillo, A Warshaw, W Steinberg, J Hermon-Taylor, J E Valenzuela, M Hariri, M Hughes, P A Banks.   

Abstract

CONCLUSIONS: Urinary TAP obtained within the first 48 h of the onset of symptoms can distinguish patients with severe acute pancreatitis.
BACKGROUND: Urinary trypsinogen activation peptide (TAP) has recently been described as an early marker of severity in acute pancreatitis.
METHODS: In a multicenter study, urine samples were collected for TAP concentration at 6-12, 24, and 48 h after admission from 139 patients with acute pancreatitis (99 with mild disease, 40 with severe disease) and from 50 control patients. Severity of acute pancreatitis was defined by the presence of organ failure and/ or pancreatic necrosis on dynamic contrast-enhanced computed tomography.
RESULTS: Median urinary TAP in the 139 patients with acute pancreatitis compared to the 50 control patients was significantly higher at admission, 4.6 vs 0.8 ng/mL (p < 0.001), and 6-12 h, 1.9 vs 0.55 ng/mL (p = 0.04). Among patients who presented within 48 h of the onset of symptoms, the median urinary TAP for severe pancreatitis (9 patients) compared to mild pancreatitis (40 patients) was significantly higher at admission, 29.6 vs. 3.6 ng/mL (p = 0.001). Also, when obtained within 48 h of the onset of symptoms, all patients with severe pancreatitis had an admission urinary TAP level > 10 ng/mL. The sensitivity and specificity of an admission urinary TAP > or = 10 for severe pancreatitis was 100 and 85%, respectively. Given a cutoff of 10 ng/mL for an admission urinary TAP obtained within 48 h of the onset of symptoms, the negative predictive value was 100% for mild pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209951     DOI: 10.1007/bf02822381

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  16 in total

Review 1.  Predictors of severity of acute pancreatitis.

Authors:  W M Steinberg
Journal:  Gastroenterol Clin North Am       Date:  1990-12       Impact factor: 3.806

2.  The Abbott IMx automated benchtop immunochemistry analyzer system.

Authors:  M Fiore; J Mitchell; T Doan; R Nelson; G Winter; C Grandone; K Zeng; R Haraden; J Smith; K Harris
Journal:  Clin Chem       Date:  1988-09       Impact factor: 8.327

Review 3.  Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation.

Authors:  H Rinderknecht
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

4.  Methemalbumin in acute pancreatitis: an evaluation of its prognostic value and comparison with multiple prognostic parameters.

Authors:  P G Lankisch; C A Schirren; J Otto
Journal:  Am J Gastroenterol       Date:  1989-11       Impact factor: 10.864

Review 5.  Acute pancreatitis.

Authors:  W Steinberg; S Tenner
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

6.  Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems.

Authors:  C Wilson; D I Heath; C W Imrie
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

7.  APACHE-II score for assessment and monitoring of acute pancreatitis.

Authors:  M Larvin; M J McMahon
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

8.  Two human trypsinogens. Purification, molecular properties, and N-terminal sequences.

Authors:  O Guy; D Lombardo; D C Bartelt; J Amic; C Figarella
Journal:  Biochemistry       Date:  1978-05-02       Impact factor: 3.162

9.  Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates.

Authors:  J Schmidt; C Fernández-del Castillo; D W Rattner; K Lewandrowski; C C Compton; A L Warshaw
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

10.  Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP).

Authors:  P R Hurley; A Cook; A Jehanli; B M Austen; J Hermon-Taylor
Journal:  J Immunol Methods       Date:  1988-07-22       Impact factor: 2.303

View more
  13 in total

Review 1.  Medical management of acute pancreatitis: strategies, reality, and potential.

Authors: 
Journal:  Curr Gastroenterol Rep       Date:  2000-04

Review 2.  Current management of acute pancreatitis.

Authors:  Thomas E Clancy; Eric P Benoit; Stanley W Ashley
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

3.  UK guidelines for the management of acute pancreatitis.

Authors: 
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 4.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

Review 5.  Optimising outcomes in acute pancreatitis.

Authors:  I D Norton; J E Clain
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: a meta-analysis.

Authors:  Wei Huang; Kiran Altaf; Tao Jin; Jun-Jie Xiong; Li Wen; Muhammad A Javed; Marianne Johnstone; Ping Xue; Christopher M Halloran; Qing Xia
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

Review 7.  Severity scoring for acute pancreatitis: where do we stand in 1999?

Authors:  L K Gates
Journal:  Curr Gastroenterol Rep       Date:  1999-04

Review 8.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Caerulein or taurocholate induced enzymatic and histologic alterations in the isolated perfused rat pancreas.

Authors:  R Mantke; D Schubert; C Röcken; I Paege; W Halangk; B Peters; H Lippert; H-U Schulz
Journal:  Langenbecks Arch Surg       Date:  2008-08-09       Impact factor: 3.445

Review 10.  Pancreatitis after endoscopic retrograde cholangio-pancreatography.

Authors:  Ayman M Abdel Aziz; Glen A Lehman
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.